CHAMARA MERCER: Open Payments
NPI 1508221409 · TAYLOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 21 payments from 5 companies in 2025. Trend: 2023 $78 · 2024 $318 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $377 |
| Alkermes, Inc. | 1 | $126 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Neurelis, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: REXULTI, LYBALVI, AUSTEDO XR, VALTOCO, UZEDY, CAPLYTA.
Industry payments across MI — which companies pay providers there.
